“Crash Global Effort Underway to Increase Coronavirus Testing”
“There’s (a) fine balance between getting the test out there fast and making sure the test is accurate,” says Dr. Tim Alcorn, Director of Medical Devices and Diagnostics at Latham …
News
Latham BioPharm Group is thrilled to announce the addition of three new team members
LBG is thrilled to announce the addition of Dr. Robert Casillas, Dr. Thijs Beuming and Dr. Darrel J. Rezac to our Team—each of whom brings unique expertise that widens the …
Watch now! Roundtable Discussion: Cell and Gene Therapies — Keep the Work In-House, or Use a Third Party?
LBG’s Dr. Joseph Rininger, as an industry leader in Cell & Gene Therapies, was invited to participate in a roundtable discussion at BIO International 2019 on this topic. Questions posed to the panel by BioProcess Insider editor Dan …
Capacity Analysis for Viral Vector Manufacturing: Is There Enough?
LBG’s Dr. Joseph Rininger, Dr. Ashley Fennell, Dr. Lauren Schoukroun-Barnes, Christopher Peterson and Dr. Joshua Speidel recently published a joint article titled, Capacity Analysis for Viral Vector Manufacturing: Is There Enough?. The article discusses …
The Importance of ROI Evaluation in the Pharmaceutical/Biotechnology Industry
Several of LBG’s consultants recently published a joint article on Return on Investment (ROI) calculations and tools used by pharmaceutical and biotechnology companies in evaluating product returns, guiding decisions on …
Innovator Requirements for the Selection of a CAR-T CDMO
LBG consultants Lauren R. Schoukroun-Barnes, Joseph Rininger, Kristi Sarno, and Susan Dexter interviewed CAR-T Innovators and Manufacturers to better understand the difficulties surrounding manufacturing. Specifically, the Innovators were asked about …
Outsourcing Biosimilar Development – Featured Report
LBG consultants Kristi Sarno and Cassidy Cantin performed market research and analyzed the results in an article “Outsourcing Biosimilar Development“, published in BioProcess International’s March 2017 Featured Report. LBG interviewed six executives at companies that are …